Pulse Biosciences shares are trading higher after the company announced it received the Breakthrough Device Designation from the FDA for its Cardiac Surgery System for the ablation of cardiac tissue for the treatment of atrial fibrillation.
$PLSE
Medical/Dental Instruments
Health Care
Pulse Biosciences shares are trading higher after the company announced it received the Breakthrough Device Designation from the FDA for its Cardiac Surgery System for the ablation of cardiac tissue for the treatment of atrial fibrillation.